Vincent Amodru

Vincent Amodru

Auto-generated profile, based on publicly available information

Vincent Amodru

IIB-Sant Pau and Department of Endocrinology, Hospital Sant Pau, Dept Medicine , UAB, and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII, Barcelona , Spain Aix-Marseille Université , Institut National de la Santé et de la Recherche Médicale INSERM U1251, Marseille Medical Genetics, Marseille, France and Assistance Publique Hôpitaux de Marseille (APHM), Hôpital de la Conception, Marseille , France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2023 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
VAVincent Amodru
Vincent Amodru
AFAmandine Ferriere
Amandine Ferriere
ATAntoine Tabarin
Antoine Tabarin
FCFrederic Castinetti
Frederic Castinetti
STStylianos Tsagarakis
Stylianos Tsagarakis
EVElena Valassi
Elena Valassi
Objective: To evaluate whether age-related differences exist in clinical characteristics, diagnostic approach, and management strategies in patients with Cushing's syndrome (CS) included in the European Registry on Cushing's Syndrome (ERCUSYN).Design: Cohort study.Methods: We analyzed 1791 patients with CS, of whom 1234 (69%) had pituitary-dependent CS (PIT-CS), 450 (25%) adrenal-dependent CS (ADR-CS), and 107 (6%) had an ectopic source (ECT-CS). According to the WHO criteria, 1616 patients (90.2%) were classified as younger (<65 years old) and 175 (9.8%) as older (≥65 years old).Results: Older patients were more frequently males and had a lower Body Mass Index (BMI) and waist circumference when compared with the younger. Older patients also had a lower prevalence of skin alterations, depression, hair loss, hirsutism, and reduced libido, but a higher prevalence of muscle weakness, diabetes, hypertension, cardiovascular disease, venous thromboembolism, and bone fractures than younger patients, regardless of sex (P < .01 for all comparisons). Measurement of urinary free cortisol supported the diagnosis of CS less frequently in older patients when compared with the younger (P < .05). An extrasellar macroadenoma (macrocorticotropinoma with extrasellar extension) was more common in older PIT-CS patients than in the younger (P < .01). Older PIT-CS patients more frequently received cortisol-lowering medications and radiotherapy as a first-line treatment, whereas surgery was the preferred approach in the younger (P < .01 for all comparisons). When transsphenoidal surgery was performed, the remission rate was lower in the elderly when compared with their younger counterpart (P < .05).Conclusions: Older CS patients lack several typical symptoms of hypercortisolism, present with more comorbidities regardless of sex, and are more often conservatively treated.

24 December 2018 in Head & Neck
Verified
Journal Article
Open access
PDF file
VAVincent Amodru
Vincent Amodru
PRPauline Romanet
Pauline Romanet
USUgo Scemama
Ugo Scemama
MMMarion Montava
Marion Montava
NFNicolas Fakhry
Nicolas Fakhry
DTDavid Taïeb
David Taïeb
Background: 18F‐FDOPA PET/CT was proved to be a highly sensitive imaging method for detecting head and neck paraganglioma (HNPGL). The primary aim of the study was to evaluate the relationship between tumor characteristics and the SDHx‐mutational status in a large series of patients with HNPGL evaluated by 18F‐FDOPA PET/CT.Methods: A total of 104 patients with HNPGL (65 sporadic/39 SDHx‐mutated) were included.Results: In comparison to SDHB/SDC/SDHx‐negative cases, patients with SDHD were younger at diagnosis and had a higher rate of multifocal, vagal, and carotid paraganglioma. In patients with SDHD, vagal paraganglia represented the primary site of tumor origin. Multicentric involvement of the vagus nerve alone or in association with other locations was found to be a typical feature of SDHD cases compared to other cases (odds ratio = 59.4).Conclusion: The present study shows that tumor multifocality within the vagus nerve is a phenotypic marker of SDHD mutation. This information is essential in the choice of the therapeutic strategy.

24 September 2022 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
VAV. Amodru
V. Amodru
NSN. Sahakian
N. Sahakian
CPC. Piazzola
C. Piazzola
TGT. Graillon
T. Graillon
TCT. Cuny
T. Cuny
FCF. Castinetti
F. Castinetti